The production of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, requires a complex complicated organic process. Initial routes focused on amino acid chain section coupling, utilizing solid-phase creation methodologies to build the long protein sequence. Subsequent research has explored alternative approaches, includin… Read More